SLDB Similar Chart Price Prediction
The price of SLDB is predicted to go up -44.44%, based on the high correlation periods with RVYL. The similarity of these two price pattern on the periods is 98.12%.
SLDB
RVYL
Down: -44.44%Similarity: 98.12%
SLDB Revenue Forecast
SLDB EPS Forecast
SLDB FAQs
What is bull’s view on SLDB?
What is bear's view on SLDB?
What is SLDB eps forecast for next quarter？
SLDB Analyst's Forecast
Geulah Livshits
Chardan Capital
Strong Buy
2025-02-19
Price Target
$15 → $16
Upside
+147.3%
Chardan raised the firm's price target on Solid Biosciences to $16 from $15 and keeps a Buy rating on the shares. The company has reported initial clinical data from the first 3 patients in the phase 1/2 INSPIRE DUCHENNE trial evaluating SGT-003, showing robust vector transduction and microdystrophin expression in the muscle, improvements in biomarkers of muscle integrity, and early signals of potential cardiac benefit, and based on these early activity signals in conjunction with acceptable safety, the firm is increasing its probability of success for the program to 48%, the analyst tells investors in a research note.
Laura Chico
Wedbush
Buy
2024-12-13
Price Target
$16
Upside
+225.87%
Silvan Tuerkcan
JMP Securities
Buy
2024-12-10
Price Target
$15
Upside
+199.4%
